View in EDS HTML Full Text PDF Full Text

Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidaemia and atherosclerosis development in APOE*3-Leiden.CETP mice.

Saved in:
Bibliographic Details
Title: Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidaemia and atherosclerosis development in APOE*3-Leiden.CETP mice.
Authors: Modder M; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Het Panhuis WI; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Li M; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Afkir S; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Dorn AL; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Pronk ACM; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Streefland TCM; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Lalai RA; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Pierrou S; Lipigon Pharmaceuticals AB, Tvistevägen 48C, 907 36 Umeå, Sweden., Nilsson SK; Lipigon Pharmaceuticals AB, Tvistevägen 48C, 907 36 Umeå, Sweden., Olivecrona G; Lipigon Pharmaceuticals AB, Tvistevägen 48C, 907 36 Umeå, Sweden.; Department of Medical Biosciences, Umeå University, Umeå, Sweden., Kooijman S; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Rensen PCN; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Schönke M; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Source: Cardiovascular research [Cardiovasc Res] 2024 Dec 31; Vol. 120 (17), pp. 2179-2190.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39259836
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidaemia and atherosclerosis development in APOE*3-Leiden.CETP mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Modder+M%22">Modder M</searchLink>; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Het+Panhuis+WI%22">Het Panhuis WI</searchLink>; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Afkir+S%22">Afkir S</searchLink>; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dorn+AL%22">Dorn AL</searchLink>; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Pronk+ACM%22">Pronk ACM</searchLink>; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Streefland+TCM%22">Streefland TCM</searchLink>; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lalai+RA%22">Lalai RA</searchLink>; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Pierrou+S%22">Pierrou S</searchLink>; Lipigon Pharmaceuticals AB, Tvistevägen 48C, 907 36 Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Nilsson+SK%22">Nilsson SK</searchLink>; Lipigon Pharmaceuticals AB, Tvistevägen 48C, 907 36 Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Olivecrona+G%22">Olivecrona G</searchLink>; Lipigon Pharmaceuticals AB, Tvistevägen 48C, 907 36 Umeå, Sweden.; Department of Medical Biosciences, Umeå University, Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Kooijman+S%22">Kooijman S</searchLink>; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rensen+PCN%22">Rensen PCN</searchLink>; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schönke+M%22">Schönke M</searchLink>; Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220077427%22">Cardiovascular research</searchLink> [Cardiovasc Res] 2024 Dec 31; Vol. 120 (17), pp. 2179-2190.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+Journals%22">Oxford Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0077427 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1755-3245 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200086363%22">00086363 </searchLink><i>NLM ISO Abbreviation: </i>Cardiovasc Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39259836
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cvr/cvae195
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2179
    Titles:
      – TitleFull: Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidaemia and atherosclerosis development in APOE*3-Leiden.CETP mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Modder M
      – PersonEntity:
          Name:
            NameFull: Het Panhuis WI
      – PersonEntity:
          Name:
            NameFull: Li M
      – PersonEntity:
          Name:
            NameFull: Afkir S
      – PersonEntity:
          Name:
            NameFull: Dorn AL
      – PersonEntity:
          Name:
            NameFull: Pronk ACM
      – PersonEntity:
          Name:
            NameFull: Streefland TCM
      – PersonEntity:
          Name:
            NameFull: Lalai RA
      – PersonEntity:
          Name:
            NameFull: Pierrou S
      – PersonEntity:
          Name:
            NameFull: Nilsson SK
      – PersonEntity:
          Name:
            NameFull: Olivecrona G
      – PersonEntity:
          Name:
            NameFull: Kooijman S
      – PersonEntity:
          Name:
            NameFull: Rensen PCN
      – PersonEntity:
          Name:
            NameFull: Schönke M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 12
              Text: 2024 Dec 31
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1755-3245
          Numbering:
            – Type: volume
              Value: 120
            – Type: issue
              Value: 17
          Titles:
            – TitleFull: Cardiovascular research
              Type: main
ResultId 1